Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Pacira will begin "shortly" the Phase III portion of a 2-part, double-blind, placebo-controlled Phase II/III trial of Exparel in about 280
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury